EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2022 update on diagnosis, risk-stratification, and management.
Malpica L, Marques-Piubelli ML, Beltran BE, Chavez JC, Miranda RN, Castillo JJ.
Am J Hematol. 2022 Jul;97(7):951-965. doi: 10.1002/ajh.26579. Epub 2022 May 3.
Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly: a concise review and update.
Hong JY, Ko YH, Kim SJ, Kim WS.
Curr Opin Oncol. 2015 Sep;27(5):392-8. doi: 10.1097/CCO.0000000000000210.
Epstein-barr virus-positive diffuse large B-cell lymphoma of the elderly: what we know so far.
Castillo JJ, Beltran BE, Miranda RN, Paydas S, Winer ES, Butera JN.
Oncologist. 2011;16(1):87-96. doi: 10.1634/theoncologist.2010-0213. Epub 2011 Jan 6.
Epstein-Barr virus positive diffuse large B-cell lymphoma of the elderly.
Wong HH, Wang J.
Leuk Lymphoma. 2009 Mar;50(3):335-40. doi: 10.1080/10428190902725813.
EBV-positive diffuse large B-cell lymphoma of the elderly.
Ok CY, Papathomas TG, Medeiros LJ, Young KH.
Blood. 2013 Jul 18;122(3):328-40. doi: 10.1182/blood-2013-03-489708. Epub 2013 May 6.
EBV-positive diffuse large B-cell lymphoma of the elderly: 2016 update on diagnosis, risk-stratification, and management.
Castillo JJ, Beltran BE, Miranda RN, Young KH, Chavez JC, Sotomayor EM.
Am J Hematol. 2016 May;91(5):529-37. doi: 10.1002/ajh.24370.
Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy.
Hamilton MP, Sugio T, Noordenbos T, Shi S, Bulterys PL, Liu CL, Kang X, Olsen MN, Good Z, Dahiya S, Frank MJ, Sahaf B, Mackall CL, Gratzinger D, Diehn M, Alizadeh AA, Miklos DB.
N Engl J Med. 2024 Jun 13;390(22):2047-2060. doi: 10.1056/NEJMoa2401361.
Epstein-Barr virus-positive diffuse large B-cell lymphomas of the elderly.
Adam P, Bonzheim I, Fend F, Quintanilla-Martínez L.
Adv Anat Pathol. 2011 Sep;18(5):349-55. doi: 10.1097/PAP.0b013e318229bf08.
[Updates on Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly].
Liu F, Zhang L, Yin W, Mei K, Li X.
Zhonghua Bing Li Xue Za Zhi. 2015 Feb;44(2):135-9.
Defective Epstein-Barr virus in chronic active infection and haematological malignancy.
Okuno Y, Murata T, Sato Y, Muramatsu H, Ito Y, Watanabe T, Okuno T, Murakami N, Yoshida K, Sawada A, Inoue M, Kawa K, Seto M, Ohshima K, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Narita Y, Yoshida M, Goshima F, Kawada JI, Nishida T, Kiyoi H, Kato S, Nakamura S, Morishima S, Yoshikawa T, Fujiwara S, Shimizu N, Isobe Y, Noguchi M, Kikuta A, Iwatsuki K, Takahashi Y, Kojima S, Ogawa S, Kimura H.
Nat Microbiol. 2019 Mar;4(3):404-413. doi: 10.1038/s41564-018-0334-0. Epub 2019 Jan 21.
